Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › CAR-T

CAR-T

2 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
ctDNA and immune profiling offer a pathway toward individualized treatment for recurrent colorectal cancer
Hematology Sys. Review
ctDNA and immune profiling offer a pathway toward individualized treatment for recurrent colorectal cancer New tools help identify high risk of colorectal cancer relapse
This mini review explores ctDNA-guided surveillance, immune checkpoint blockade, and engineered cell therapies for patients with colorectal …
Doctors are using blood tests and immune profiling to better predict when colorectal cancer might return after treatment.
Frontiers Jul 23, 2026
T cell-based therapies show promise but face barriers in solid tumors
Oncology Sys. Review
T cell-based therapies show promise but face barriers in solid tumors CAR-T and TIL therapies face hurdles in treating solid tumors
This narrative review examines CAR-T, TIL, and TCE therapies for hematologic and solid malignancies. Key challenges include on-target/off-tu…
A review notes that CAR-T, TIL, and TCE therapies struggle with tumor microenvironments and manufacturing issues for solid cancers.
Frontiers Jun 2, 2026